Insider · CIK 0001838539

Schneider Eugene

Reports to the SEC for 1 company · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001838539

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+26K sh	$60.89	+$1.58M	103,114
2026-06-26	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−26K sh	$81.05	−$2.11M	77,114
2026-06-26	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−26K sh	—	—	26,000
2026-03-19	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−5,812 sh	$70.97	−$412K	63,890
2026-01-30	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−6,179 sh	$83.45	−$516K	69,702
2026-01-29	IONSIONIS PHARMACEUTICALS INCA Award	EVP, Chf Clinical Develop Ofcr	AAward	+12K sh	—	—	75,881
2026-01-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−9,302 sh	$75.59	−$703K	63,890
2026-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+21.7K sh	—	—	73,192
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chf Clinical Develop Ofcr	AAward	+25.8K sh	—	—	91,237
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−21.7K sh	—	—	39,251
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chf Clinical Develop Ofcr	AAward	+9,675 sh	—	—	48,926
2026-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf Clinical Develop Ofcr	AAward	+19.4K sh	—	—	19,350
2025-09-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+19.7K sh	$53.77	+$1.06M	71,165
2025-09-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−12.5K sh	$60.46	−$753K	58,710
2025-09-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−7,203 sh	$61.42	−$442K	51,507
2025-09-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−19.7K sh	—	—	0
2025-08-04	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−9,549 sh	$42.80	−$409K	51,507
2025-01-31	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−1,484 sh	$32.20	−$47.8K	61,056
2025-01-30	IONSIONIS PHARMACEUTICALS INCA Award	EVP, Chf Clinical Develop Ofcr	AAward	+4,032 sh	—	—	62,540
2025-01-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−6,523 sh	$32.79	−$214K	58,508
2025-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+17.4K sh	—	—	65,031
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chf Clinical Develop Ofcr	AAward	+22K sh	—	—	65,437
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chf Clinical Develop Ofcr	AAward	+33K sh	—	—	78,308
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−17.4K sh	—	—	60,936
2025-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf Clinical Develop Ofcr	AAward	+22K sh	—	—	22,000
2024-02-02	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−2,071 sh	$49.59	−$103K	49,812
2024-02-02	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−2,106 sh	$49.59	−$104K	47,659
2024-02-01	IONSIONIS PHARMACEUTICALS INCA Award	EVP, Chf Clinical Develop Ofcr	AAward	+4,033 sh	—	—	51,883
2024-01-17	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−5,482 sh	$50.42	−$276K	47,850
2024-01-16	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+15.2K sh	—	—	53,332
2024-01-16	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−15.2K sh	—	—	45,308
2024-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chf Clinical Develop Ofcr	AAward	+17K sh	—	—	43,437
2024-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chf Clinical Develop Ofcr	AAward	+20.4K sh	—	—	60,470
2024-01-12	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+8,000 sh	$32.60	+$261K	46,170
2024-01-12	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−8,000 sh	$53.50	−$428K	38,170
2024-01-12	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−8,000 sh	—	—	24,265
2024-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf Clinical Develop Ofcr	AAward	+27.2K sh	—	—	27,200
2023-12-26	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+25K sh	$47.34	+$1.18M	61,052
2023-12-26	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−25K sh	$51.46	−$1.29M	36,052
2023-12-26	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−25K sh	—	—	0
2023-02-06	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−1,413 sh	$40.67	−$57.5K	24,946
2023-02-03	IONSIONIS PHARMACEUTICALS INCA Award	EVP, Chf Clinical Develop Ofcr	AAward	+4,033 sh	—	—	26,359
2023-01-18	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chf Clinical Develop Ofcr	SSale	−4,752 sh	$39.57	−$188K	22,326
2023-01-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+13K sh	—	—	27,078
2023-01-17	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	−13K sh	—	—	40,070
2023-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chf Clinical Develop Ofcr	AAward	+14.3K sh	—	—	26,437
2023-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chf Clinical Develop Ofcr	AAward	+17.2K sh	—	—	53,116
2023-01-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chf Clinical Develop Ofcr	AAward	+22.9K sh	—	—	22,942
2022-10-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chf Clinical Develop Ofcr	MExercise/Conversion	+416 sh	—	—	14,176
2022-10-17	IONSIONIS PHARMACEUTICALS INCF Tax Payment	EVP, Chf Clinical Develop Ofcr	FTax Payment	−144 sh	$46.52	−$6,698.88	14,032

Recent filings

Accepted (ET)
Jun 304
Schneider Eugene0000874015-26-000216
SEC(opens sec.gov)
Mar 234
Schneider Eugene0000874015-26-000152
SEC(opens sec.gov)
Feb 24
Schneider Eugene0000874015-26-000101
SEC(opens sec.gov)
Jan 204
Schneider Eugene0000874015-26-000071
SEC(opens sec.gov)
Jan 64
Schneider Eugene0000874015-26-000025
SEC(opens sec.gov)
Sep 44
Schneider Eugene0000874015-25-000211
SEC(opens sec.gov)
Aug 54
Schneider Eugene0000874015-25-000172
SEC(opens sec.gov)
Feb 34
Schneider Eugene0000874015-25-000080
SEC(opens sec.gov)
Jan 174
Schneider Eugene0000874015-25-000064
SEC(opens sec.gov)

Companies

IONIS PHARMACEUTICALS INCEVP, Chf Clinical Develop OfcrIONS

Address

2855 GAZELLE COURT

CARLSBAD, CA, 92010